TrialAntimicrobial agents and chemotherapy2000

Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies.

J M Barnett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.